Suven Life Sciences Ltd Nine Monthly Results

Gross Sales

5.19

9.31

10.93

7.62

11.92

Excise Duty

0

0

0

0

0

Net Sales

5.19

9.31

10.93

7.62

11.92

Other Operating Income

0

0

0

0

0

Other Income

9.67

24.3

8.85

5.2

6.43

Total Income

14.86

33.61

19.77

12.82

18.35

Total Expenditure

127.14

107.02

105.29

110.3

70.41

PBIDT

-112.28

-73.41

-85.52

-97.47

-52.05

Interest

0.05

0.13

0.24

0.43

0.57

PBDT

-112.33

-73.54

-85.75

-97.91

-52.63

Depreciation

4.48

4.99

4.87

3.29

3.28

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

0

0

0

0

-5.37

Reported Profit After Tax

-116.8

-78.54

-90.62

-101.2

-50.54

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-116.8

-78.54

-90.62

-101.2

-50.54

Extra-ordinary Items

0

7.46

6

3.72

0

Adjusted Profit After Extra-ordinary item

-116.8

-86

-96.62

-104.92

-50.54

EPS (Unit Curr.)

-5.36

-3.6

-5.46

-7.51

-3.97

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

21.81

21.81

21.81

12.73

12.73

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-2,163.39

-788.5

-782.43

-1,279.13

-436.66

PBDTM(%)

-2,164.35

-789.9

-784.53

-1,284.9

-441.52

PATM(%)

-2,250.48

-843.6

-829.09

-1,328.08

-423.99